Treatment of Patients With Acute Sinusitis

For each patient, an initial visit and at least one follow-up visit at the end of treatment should be documented by the treating physician in the case report form.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Acute Bacterial Sinusitis Infections Nose Diseases Otorhinolaryngologic Diseases Paranasal Sinus Diseases Respiratory Tract Diseases Respiratory Tract Infections Sinusitis

Sex eligibility

All sexes

Study type

Observational

Primary location

Many Locations, Austria

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Any patient with a diagnosis of acute bacterial sinusitis treated with Avelox® - in accordance with the local production information.

Exclusion criteria

Those specified in the local product information - contraindications and precautions must be considered.

Treatment and study plan

Avelox (Moxifloxacin, BAY12-8039)

Drug

Patients with a diagnosis of acute bacterial sinusitis who take moxifloxacin

Primary outcomes

Evaluation of potential benefits of an antibacterial therapy with Avelox® (moxifloxacin) in patients with acute bacterial sinusitis to whom this treatment was prescribed. Especially the time to improvement and resolution of clinical signs and symptoms of

Time frame: Documentation at baseline and at at least one follow-up visit. Evaluation of therapy outcome at last follow-up visit at end of therapy (approximately after 7 days).

Secondary outcomes

Evaluation of tolerability and safety of Avalox® in daily practice were investigated.

Time frame: Evaluation of therapy outcome at last follow-up visit at end of therapy (approximately after 7 days).
Patient characteristics in acute bacterial sinusitis

Time frame: Documentation at baseline visit.
History and frequency of sinusitis episodes

Time frame: Documentation at baseline visit.
Diagnostic procedures and therapeutic options chosen by physicians in daily practice

Time frame: Documentation at baseline visit.

Sponsors and collaborators

Lead sponsor

Bayer

Industry

Registry information

Official study title

Treatment of Patients With Acute Sinusitis in Daily Practice

Important dates

Study start: 2007
Primary completion: 2008
Study completion: 2008
First posted: Jun 30, 2009
Registry last updated: Nov 20, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed